Baidu
map

神经外科指南

订阅

MedSci主页 / 所有栏目 / 神经外科指南

急性大血管闭塞性缺血性卒中血管内治疗中国专家共识（2017）

2017-09-30 国家卫生计生委脑卒中防治工程委员会 中华神经外科杂志.2017.33(9):869-877.

大血管闭塞血管内治疗缺血性卒中

目前我国各地区医疗条件和水平差异较大，急性大血管闭塞性缺血性卒中(AIS—LVO)的血管内治疗开展情况参差不齐，治疗效果同质性差，为进一步规范血管内治疗的操作流程，撰写组总结了国内外近年的研究结果，围绕影响临床预后的4个主要方面(快速诊治流程、适宜患者的选择、成功血管再通、规范术后管理)，结合我国实际情况制定了本专家共识。

中文标题：

急性大血管闭塞性缺血性卒中血管内治疗中国专家共识（2017）

发布机构：

国家卫生计生委脑卒中防治工程委员会

发布日期：

2017-09-30

简要介绍：

目前我国各地区医疗条件和水平差异较大，急性大血管闭塞性缺血性卒中(AIS—LVO)的血管内治疗开展情况参差不齐，治疗效果同质性差，为进一步规范血管内治疗的操作流程，撰写组总结了国内外近年的研究结果，围绕影响临床预后的4个主要方面(快速诊治流程、适宜患者的选择、成功血管再通、规范术后管理)，结合我国实际情况制定了本专家共识。

 

拓展指南：与缺血性卒中相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=急性大血管闭塞性缺血性卒中血管内治疗中国专家共识（2017）)] GetToolGuiderByIdResponse(projectId=1, id=c62191c001516335, title=急性大血管闭塞性缺血性卒中血管内治疗中国专家共识（2017）, enTitle=, guiderFrom=中华神经外科杂志.2017.33(9):869-877., authorId=null, author=, summary=目前我国各地区医疗条件和水平差异较大，急性大血管闭塞性缺血性卒中(AIS—LVO)的血管内治疗开展情况参差不齐，治疗效果同质性差，为进一步规范血管内治疗的操作流程，撰写组总结了国内外近年的研究结果，围绕影响临床预后的4个主要方面(快速诊治流程、适宜患者的选择、成功血管再通、规范术后管理)，结合我国实际情况制定了本专家共识。 , cover=, journalId=null, articlesId=null, associationId=1217, associationName=国家卫生计生委脑卒中防治工程委员会, associationIntro=国家卫生计生委脑卒中防治工程委员会 , copyright=0, guiderPublishedTime=Sat Sep 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>目前我国各地区医疗条件和水平差异较大，急性大血管闭塞性缺血性卒中(AIS—LVO)的血管内治疗开展情况参差不齐，治疗效果同质性差，为进一步规范血管内治疗的操作流程，撰写组总结了国内外近年的研究结果，围绕影响临床预后的4个主要方面(快速诊治流程、适宜患者的选择、成功血管再通、规范术后管理)，结合我国实际情况制定了本专家共识。 </P> <P> </P>拓展指南：<strong>与<font color=red>缺血性卒中</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=0ad021c001a882a8" title="缺血性卒中脑侧支循环评估与干预中国指南（2017）" target=_blank>缺血性卒中脑侧支循环评估与干预中国指南（2017）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=01be01c001a869f5" title="欧洲卒中组织(ESO)关于无活动能力的急性缺血性卒中患者静脉血栓栓塞的预防指南（翻译版）" target=_blank>欧洲卒中组织(ESO)关于无活动能力的急性缺血性卒中患者静脉血栓栓塞的预防指南（翻译版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1f5781c001a15e8f" title="2016 ICSI卫生保健指南：缺血性卒中的诊断和初级治疗（第11版）" target=_blank>2016 ICSI卫生保健指南：缺血性卒中的诊断和初级治疗（第11版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=7168f1c001a0316d" title="急性缺血性卒中静脉溶栓中国卒中学会科学声明" target=_blank>急性缺血性卒中静脉溶栓中国卒中学会科学声明</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=110ab1c0013e02a2" title="美国心脏协会／美国卒中协会急性缺血性卒中血管内治疗早期管理指南2015年版（中文版）" target=_blank>美国心脏协会／美国卒中协会急性缺血性卒中血管内治疗早期管理指南2015年版（中文版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%BC%BA%E8%A1%80%E6%80%A7%E5%8D%92%E4%B8%AD" target=_blank>有关缺血性卒中更多指南</a></ul>, tagList=[TagDto(tagId=34970, tagName=大血管闭塞), TagDto(tagId=4160, tagName=血管内治疗), TagDto(tagId=320, tagName=缺血性卒中)], categoryList=[CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8573, appHits=405, showAppHits=0, pcHits=5265, showPcHits=3688, likes=129, shares=14, comments=10, approvalStatus=1, publishedTime=Mon Nov 06 22:59:54 CST 2017, publishedTimeString=2017-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 06 22:59:54 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:32:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=急性大血管闭塞性缺血性卒中血管内治疗中国专家共识（2017）)])
急性大血管闭塞性缺血性卒中血管内治疗中国专家共识（2017）
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=332573, encodeId=17983325e3a9, content=学习了值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Thu Jul 19 00:51:14 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317435, encodeId=99c331e435b6, content=谢谢了.有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:17 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317434, encodeId=f55231e43407, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:05 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260799, encodeId=3fec260e9949, content=好东西.很值得参考.赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6d2184980, createdName=1207fadam17(暂无昵称), createdTime=Sun Nov 12 15:58:58 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259352, encodeId=bc53259352cb, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 07 06:55:44 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2018-07-19 139173a1c0m

    学习了值得推荐

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=332573, encodeId=17983325e3a9, content=学习了值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Thu Jul 19 00:51:14 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317435, encodeId=99c331e435b6, content=谢谢了.有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:17 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317434, encodeId=f55231e43407, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:05 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260799, encodeId=3fec260e9949, content=好东西.很值得参考.赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6d2184980, createdName=1207fadam17(暂无昵称), createdTime=Sun Nov 12 15:58:58 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259352, encodeId=bc53259352cb, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 07 06:55:44 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2018-05-22 foxv3羽翼

    谢谢了.有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=332573, encodeId=17983325e3a9, content=学习了值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Thu Jul 19 00:51:14 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317435, encodeId=99c331e435b6, content=谢谢了.有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:17 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317434, encodeId=f55231e43407, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:05 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260799, encodeId=3fec260e9949, content=好东西.很值得参考.赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6d2184980, createdName=1207fadam17(暂无昵称), createdTime=Sun Nov 12 15:58:58 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259352, encodeId=bc53259352cb, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 07 06:55:44 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2018-05-22 foxv3羽翼

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=332573, encodeId=17983325e3a9, content=学习了值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Thu Jul 19 00:51:14 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317435, encodeId=99c331e435b6, content=谢谢了.有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:17 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317434, encodeId=f55231e43407, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:05 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260799, encodeId=3fec260e9949, content=好东西.很值得参考.赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6d2184980, createdName=1207fadam17(暂无昵称), createdTime=Sun Nov 12 15:58:58 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259352, encodeId=bc53259352cb, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 07 06:55:44 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2017-11-12 1207fadam17(暂无昵称)

    好东西.很值得参考.赞

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=332573, encodeId=17983325e3a9, content=学习了值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Thu Jul 19 00:51:14 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317435, encodeId=99c331e435b6, content=谢谢了.有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:17 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317434, encodeId=f55231e43407, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Tue May 22 07:17:05 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260799, encodeId=3fec260e9949, content=好东西.很值得参考.赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6d2184980, createdName=1207fadam17(暂无昵称), createdTime=Sun Nov 12 15:58:58 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259352, encodeId=bc53259352cb, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 07 06:55:44 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2017-11-07 明月清辉

    谢谢分享.学习了

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map